Mehran Amoui

1.3k total citations
26 papers, 1.1k citations indexed

About

Mehran Amoui is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Mehran Amoui has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Oncology. Recurrent topics in Mehran Amoui's work include Bone Metabolism and Diseases (12 papers), Protein Tyrosine Phosphatases (9 papers) and Alkaline Phosphatase Research Studies (4 papers). Mehran Amoui is often cited by papers focused on Bone Metabolism and Diseases (12 papers), Protein Tyrosine Phosphatases (9 papers) and Alkaline Phosphatase Research Studies (4 papers). Mehran Amoui collaborates with scholars based in United States and Czechia. Mehran Amoui's co-authors include Graeme Mardon, Rui Chen, Zhihuan Zhang, K.‐H. William Lau, Lubica Dráberová, Patricia von Dippe, Petr Dráber, Daniel Levy, David J. Baylink and Matilda H.‐C. Sheng and has published in prestigious journals such as Cell, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Mehran Amoui

26 papers receiving 1.1k citations

Peers

Mehran Amoui
S Winitz United States
Ian Giddings United Kingdom
Lenora W. M. Loo United States
Clare M. Heyworth United Kingdom
Saya Ito Japan
Arthur G. Balliet United States
Nancy L. Johnson United States
Bruce D. Cuevas United States
S Winitz United States
Mehran Amoui
Citations per year, relative to Mehran Amoui Mehran Amoui (= 1×) peers S Winitz

Countries citing papers authored by Mehran Amoui

Since Specialization
Citations

This map shows the geographic impact of Mehran Amoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehran Amoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehran Amoui more than expected).

Fields of papers citing papers by Mehran Amoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehran Amoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehran Amoui. The network helps show where Mehran Amoui may publish in the future.

Co-authorship network of co-authors of Mehran Amoui

This figure shows the co-authorship network connecting the top 25 collaborators of Mehran Amoui. A scholar is included among the top collaborators of Mehran Amoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehran Amoui. Mehran Amoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stiffel, Virginia M., Mehran Amoui, Matilda H.‐C. Sheng, Subburaman Mohan, & K.‐H. William Lau. (2013). EphA4 Receptor Is a Novel Negative Regulator of Osteoclast Activity. Journal of Bone and Mineral Research. 29(4). 804–819. 28 indexed citations
3.
Sheng, Matilda H.‐C., Jon E. Wergedal, Subburaman Mohan, et al.. (2012). Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice. PLoS ONE. 7(4). e35280–e35280. 24 indexed citations
5.
Sheng, Matilda H.‐C., Mehran Amoui, Virginia M. Stiffel, et al.. (2009). Targeted Transgenic Expression of an Osteoclastic Transmembrane Protein-tyrosine Phosphatase in Cells of Osteoclastic Lineage Increases Bone Resorption and Bone Loss in Male Young Adult Mice. Journal of Biological Chemistry. 284(17). 11531–11545. 22 indexed citations
6.
Amoui, Mehran, Matilda H.‐C. Sheng, Shin‐Tai Chen, David J. Baylink, & K.‐H. William Lau. (2007). A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFκB and JNK2. Archives of Biochemistry and Biophysics. 463(1). 47–59. 28 indexed citations
7.
Amoui, Mehran, et al.. (2007). Characterization and comparison of the intronic promoter of murine osteoclastic protein-tyrosine phosphatase, PTP-oc, with the human PTP-oc promoter. Archives of Biochemistry and Biophysics. 465(1). 72–81. 10 indexed citations
9.
Lau, K.‐H. William, et al.. (2005). An osteoclastic protein‐tyrosine phosphatase is a potential positive regulator of the c‐Src protein‐tyrosine kinase activity: A mediator of osteoclast activity. Journal of Cellular Biochemistry. 97(5). 940–955. 24 indexed citations
10.
Amoui, Mehran, et al.. (2004). An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells. American Journal of Physiology-Cell Physiology. 287(4). C874–C884. 30 indexed citations
11.
Amoui, Mehran, David J. Baylink, John B. Tillman, & K.‐H. William Lau. (2003). Expression of a Structurally Unique Osteoclastic Protein-tyrosine Phosphatase Is Driven by an Alternative Intronic, Cell Type-specific Promoter. Journal of Biological Chemistry. 278(45). 44273–44280. 31 indexed citations
12.
Harris, Joseph, Donna D. Strong, Mehran Amoui, David J. Baylink, & K.‐H. William Lau. (2002). Construction of a Tc1-like transposon Sleeping Beauty-based gene transfer plasmid vector for generation of stable transgenic mammalian cell clones. Analytical Biochemistry. 310(1). 15–26. 10 indexed citations
13.
Amoui, Mehran, et al.. (2001). Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. Journal of Endocrinology. 171(1). 153–162. 17 indexed citations
14.
Amoui, Mehran & W. Todd Miller. (2000). The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk. Cellular Signalling. 12(9-10). 637–643. 11 indexed citations
15.
Nguyen, Jack, Margaret Porter, Mehran Amoui, et al.. (2000). Improving SH3 domain ligand selectivity using a non-natural scaffold. Chemistry & Biology. 7(7). 463–473. 99 indexed citations
16.
Amoui, Mehran, Petr Dráber, & Lubica Dráberová. (1997). Src family‐selective tyrosine kinase inhibitor, PP1, inhibits both FcεRI‐ and Thy‐1‐mediated activation of rat basophilic leukemia cells. European Journal of Immunology. 27(8). 1881–1886. 71 indexed citations
17.
Chen, Rui, Mehran Amoui, Zhihuan Zhang, & Graeme Mardon. (1997). Dachshund and Eyes Absent Proteins Form a Complex and Function Synergistically to Induce Ectopic Eye Development in Drosophila. Cell. 91(7). 893–903. 328 indexed citations
18.
Amoui, Mehran, et al.. (1997). Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fcε receptors. European Journal of Immunology. 27(1). 321–328. 27 indexed citations
19.
Dippe, Patricia von, Mehran Amoui, Robert H. Stellwagen, & Daniel Levy. (1996). The Functional Expression of Sodium-dependent Bile Acid Transport in Madin-Darby Canine Kidney Cells Transfected with the cDNA for Microsomal Epoxide Hydrolase. Journal of Biological Chemistry. 271(30). 18176–18180. 72 indexed citations
20.
Alves, Carlos Roberto, Patricia von Dippe, Mehran Amoui, & Daniel Levy. (1993). Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations.. Journal of Biological Chemistry. 268(27). 20148–20155. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026